Article
Bladder cancer survival in patients with NOD2 or CDKN2A variants.
Oncotarget - 1 Jan 2022
Złowocka-Perłowska Elżbieta, van de Wetering Thierry, Tołoczko-Grabarek Aleksandra, Scott Rodney J, Lubiński Jan
Abstract excerpt
PURPOSE: The association between the NOD2 c.3020insC allele and CDKN2A missense variant c.442G>A (p.P.A148T) and survival of patients with bladder or kidney cancer remains controversial. MATERIALS AND METHODS: We compared the allele frequencies of NOD2 c.3020insC and CDKN2A p.A148T allele in 706 patients with bladder cancer, 410 cases with kidney cancer against two control groups. The Cox proportional hazards...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.